VanessaW
Lv3
280 积分
2021-05-08 加入
-
Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial
5天前
已完结
-
A proof of concept for structure-based vaccine design targeting RSV in humans
6天前
已完结
-
Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial
18天前
已完结
-
Nucleic acid-based drugs for patients with solid tumours
19天前
已完结
-
Evolutionary dynamics of group A and B respiratory syncytial virus in China, 2009-2018
1个月前
已完结
-
Defining RSV epidemic season in southwest China and assessing the relationship between birth month and RSV infection: A 10‐year retrospective study from June 2009 to May 2019
1个月前
已完结
-
2014—2021年流感季中国流感疫苗估算报告接种覆盖情况分析
1个月前
已完结
-
Pfizer Launches Phase 1 mRNA Flu Vaccine Trial
2个月前
已完结
-
关于季节性流感灭活疫苗临床试验技术评价的考虑
2个月前
已完结
-
Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA
2个月前
已完结